Optimal value of fractional exhaled nitric oxide in inhaled corticosteroid treatment for patients with chronic cough of unknown cause

Journal of the Chinese Medical Association

Volumn 76, Issue 1, 2013, Pages 15-19

  Hsu, Jeng Yuan ^a,b   Wang, Chen Yu ^b   Cheng, Ya Wen ^b   Chou, Ming Chih ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cough variant asthma; Fractional exhaled nitric oxide; Inhaled corticosteroid; Nonasthmatic eosinophilic bronchitis; Upper airway cough syndrome

Indexed keywords

FLUTICASONE; NITRIC OXIDE;

ADULT; ARTICLE; BRONCHIAL HYPERRESPONSIVENESS; BRONCHUS DISEASE; COUGHING; DISEASE DURATION; FEMALE; FORCED VITAL CAPACITY; FRACTIONAL EXHALED NITRIC OXIDE; HUMAN; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT PARAMETERS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGED; BREATH TESTS; CHRONIC DISEASE; COUGH; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RETROSPECTIVE STUDIES;

EID: 84872370603     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2012.08.010     Document Type: Article

References (27)

1. Lim K.G. Nitric oxide measurement in chronic cough. Lung 2010, 188(Suppl 1):S19-S22.
2. Pratter M.R. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 2006, 129:63-71.
3. Pratter M.R., Bartter T., Akers S., DuBois J. An algorithmic approach to chronic cough. Ann Intern Med 1993, 119:977-983.
4. Brightling C.E., Ward R., Goh K.L., Wardlaw A.J., Pavord I.D. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999, 160:406-410.
5. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. New Engl J Med 2002, 346:1699-1705.
6. Chung K.F., Pavord I.D. Prevalence, pathogenesis, and causes of chronic cough. Lancet 2008, 371:1364-1374.
7. Brightling C.E. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006, 129:S116-S121.
8. Pavord I.D., Chung K.F. Management of chronic cough. Lancet 2008, 371:1375-1384.
9. Gibson P.G. How to measure airway inflammation: induced sputum. Can Respir J 1998, 5(Suppl A):A22-6.
10. Alving K., Weitzberg E., Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993, 6:1368-1370.
11. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343:133-135.
12. Jatakanon A., Lim S., Kharitonov S.A., Chung K.F., Barnes P.J. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53:91-95.
13. Sato S., Saito J., Sato Y., Ishii T., Xintao W., Tanino Y., et al. Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. Respir Med 2008, 102:1452-1459.
14. Hahn P.Y., Morgenthaler T.Y., Lim K.G. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc 2007, 82:1350-1355.
15. Olin A.C., Bake B., Toren K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 2007, 131:1852-1856.
16. Liu H.C., Hsu J.Y., Cheng Y.W., Chou M.C. Exhaled nitric oxide in a Taiwanese population: age and lung function as predicting factors. J Formos Med Assoc 2009, 108:772-777.
17. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-30.
18. Crapo R.O., Casaburi R., Coates A.L., Enright P.L., Hankinson J.L., Irvin C.G., et al. Guidelines for methacholine and exercise challenge testing - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000, 161:309-329.
19. Malerba M., Ragnoli B., Radaeli A., Tantucci C. Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. Chest 2008, 134:733-739.
20. Chatkin J.M., Ansarin K., Silkoff P.E., McClean P., Gutierrez C., Zamel N., et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999, 159:1810-1813.
21. Oh M.J., Lee J.Y., Lee B.J., Choi D.C. Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough. Chest 2008, 134:990-995.
22. Smith A.D., Cowan J.O., Brassett K.P., Filsell S., McLachlan C., Monti-Sheehan G., et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005, 172:453-459.
23. Birring S.S. Controversies in the evaluation and management of chronic cough. Am J Respir Crit Care Med 2011, 183:708-715.
24. Sun H.L., Lue K.H., Kao Y.H. Prescribing patterns of anti-asthma drugs in pediatric patients. Acta Paediatr Taiwan 2005, 46:212-218.
25. Littenberg B., Wheeler M., Smith D.S. A randomized controlled trial of oral albuterol in acute cough. J Fam Pract 1996, 42:49-53.
26. Tomerak A.A., Vyas H., Lakenpaul M., McGlashan J.J., McKean M. Inhaled beta2-agonists for treating non-specific chronic cough in children. Cochrane Database Syst Rev 2005, (3):CD005373.
27. Irwin R.S., French C.T., Smyrnios N.A., Curley F.J. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma. Arch Int Med 1997, 157:1981-1987.